|
|
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
|
5R44CA123994-06
|
$980,392
|
$333,333
|
GILLESPIE, JOHN
|
20/20 GENESYSTEMS, INC.
|
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: In vivo Feasibility Studies
|
1R43CA162629-01A1
|
$193,879
|
$193,879
|
Serrero, Ginette
|
A AND G PHARMACEUTICAL, INC.
|
|
|
Phase 0 Carboplatin Microdosing Diagnostic Trial.
|
N44CO120048-000
|
$1,499,894
|
$749,947
|
HENDERSON, PAUL
|
ACCELERATED MEDICAL DIAGNOSTICS
|
|
|
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)
|
6R44CA135967-03
|
$498,107
|
$498,107
|
Wolinsky, Jesse
|
ACUITYBIO CORPORATION
|
|
|
The Role of ATF3 in the DNA Damage Response
|
5R01CA139107-03
|
$254,412
|
$83,956
|
Yan, Chunhong
|
ALBANY MEDICAL COLLEGE
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$413,316
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$27,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$27,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$8,250
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Serum Levels of EGFR-Signaling-Network Activators/Inhibitor and Lung Cancer Risk
|
5R01CA143597-03
|
$560,055
|
$560,055
|
HO, GLORIA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Taxol: Mechanisms of Action and Resistance
|
5R01CA077263-12
|
$402,550
|
$402,550
|
HORWITZ, SUSAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy
|
5R01CA154755-02
|
$402,645
|
$201,323
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Transition State Analogues as Modulators of DNA Methylation
|
5R01CA135405-05
|
$261,900
|
$261,900
|
Schramm, Vern
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers
|
5R21CA163100-02
|
$173,887
|
$173,887
|
Shuter, Jonathan
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$32,560
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
|
5K24CA139054-03
|
$167,705
|
$167,705
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
5R01CA164468-02
|
$765,967
|
$382,984
|
Verkhusha, Vladislav
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Adolescent Smoking Cessation in Pediatric Primary Care
|
5R01CA140576-03
|
$507,732
|
$482,345
|
KLEIN, JONATHAN
|
AMERICAN ACADEMY OF PEDIATRICS
|
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$629,909
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$18,951
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$1,420,656
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RTOG Biospecimen Repository
|
5U24CA114734-07
|
$500,745
|
$50,075
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Online Social Networks for Dissemination of Smoking Cessation Interventions
|
5R01CA155369-02
|
$373,125
|
$354,469
|
Cobb, Nathan
|
AMERICAN LEGACY FOUNDATION
|
|
|
Improving Adherence to Web-based Cessation Programs: A Social Network Approach
|
5R01CA155489-02
|
$506,969
|
$506,969
|
GRAHAM, AMANDA
|
AMERICAN LEGACY FOUNDATION
|
|
|
OTHER FUNCTIONS - SMOKEFREE ORDINANCE DATABASE
|
N02CA120230-000
|
$10,000
|
$10,000
|
HALLETT, CYNTHIA
|
AMERICAN NONSMOKERS' RIGHTS FOUNDATION
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$53,478
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$829
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$58,695
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Inflammation Genes and Lung Cancer Risk
|
5R01CA127219-06
|
$510,315
|
$510,315
|
SPITZ, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Chemotherapeutic Agents with Enhanced Selectivity for the Tumor Microenvironment
|
5R01CA140674-03
|
$282,992
|
$93,387
|
PINNEY, KEVIN
|
BAYLOR UNIVERSITY
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$66,879
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Design of a real-time dosimetry prototype for use with external beam radiotherapy
|
1R41CA174042-01
|
$149,800
|
$74,900
|
Izaguirre, Enrique
|
BEST MEDICAL INTERNATIONAL, INC.
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-14
|
$95,411
|
$30,532
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-08
|
$330,937
|
$112,519
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of DOK family proteins in lung tumor suppression
|
5R01CA142787-03
|
$350,219
|
$350,219
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S1
|
$300,000
|
$33,000
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S2
|
$139,989
|
$15,399
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
|
The MB-CCOP at Boston Medical Center
|
5U10CA139519-03
|
$310,336
|
$34,137
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
|
Flexible, Conformal, Polymeric Films for Lung Resection Margins
|
5R01CA149561-02
|
$345,579
|
$345,579
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY
|
|
|
Bilateral oophorectomy and cancer risk and mortality in African American women
|
5R03CA162103-02
|
$61,751
|
$20,995
|
Boggs, Deborah
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing
|
3R01CA141587-04S2
|
$67,510
|
$64,135
|
BROOKS, DANIEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing
|
5R01CA141587-04
|
$569,606
|
$541,126
|
BROOKS, DANIEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
1UM1CA164974-01A1
|
$2,196,670
|
$439,334
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Defining lineage-specific determinants of K-Ras "addiction" in human cancers
|
4R00CA149169-03
|
$249,000
|
$82,170
|
SINGH, ANURAG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Molecular biomarkers of airway and lung linking COPD and Lung Cancer
|
5R01CA164783-02
|
$535,797
|
$535,797
|
SPIRA, Avrum
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Improving decisions about evaluating pulmonary nodules for lung cancer
|
5K07CA138772-05
|
$169,236
|
$169,236
|
Wiener, Renda
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Lung Sparing for SBRT with beam's-eye-view images and real time tumor tracking
|
5R21CA156068-02
|
$197,100
|
$197,100
|
Berbeco, Ross
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$13,707
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$52,767
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Total relevant funding to Lung for this search: $314,637,661
|
